Integer Q4 sales $413M (+11%), adj EPS $1.39; 2023 sales $1.6B (+16%); 2024 guidance 9-11% growth

Integer Holdings Corp

2023-FY EPS reported $2.69 revenue$1,596,673,000

Q4 sales $413M (+11% YoY), GAAP income $26M (+54%), adj EPS $1.39, adj EBITDA $86M.
Full-year 2023: sales $1.597B (+16%), adj EPS $4.67, adj EBITDA $309M (+21%).
C&V segment sales +20% in Q4 and full year; Electrochem sales -42% in Q4 on normalized run-rate.
Acquired Pulse Technologies for ~$140M (Jan 2024); 2023 sales $42.5M, adj EBITDA $11M, expected accretive.
2024 guidance: sales $1.735-1.770B (+9-11%), adj operating income +13-20%, adj EPS $5.01-$5.43.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Integer Holdings Corp reported three and twelve months ended December 31, 2023 results: revenue $413 million, net income $26 million, EPS $0.78 per share. Guidance raised.

Period: three and twelve months ended December 31, 2023
Revenue: $413 million
Net income: $26 million
EPS: $0.78 per share
Guidance: raised
Result: reported results

Exact text from the filing

all results and comparisons are from continuing operations. Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022 , except as noted) Sales increased 11% to $413 million. GAAP income from continuing operations increased $9 million to $26 million, an increase of 54%. Adjusted net income increased $10 million to $47 million, an increase of 28%.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Integer Holdings Corp filing history →

Source: SEC EDGAR

accession 0001171843-24-000822

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.